About Us

S.T. Stent was founded in late 2013 and operates within Trendlines Medical, a business incubator that is part of The Trendlines Group.


Joseph Flomenblit, Ph.D., CEO
More than 25 years’ experience developing stents; international expert in nitinol alloy; scientific advisor for Boston Scientific, J &J, Stryker, Velocimed, Rafael; leads international projects with global healthcare players; founder of Litana Ltd.; inventor, with more than 60 patents; Ph.D., physics

Gregory Frenklach, Chief Engineer
International expert in inventive problem-solving theory (TRIZ); 15 years’ experience in medical device industry; former head of mechanical design at Medinol; consults to medical device start-ups; M.Sc. engineering

Lena Shlossberg, QA Manager
Medical research experience at Sheba Medical Center; regulatory experience at Mediwound Ltd.; M.Sc. biology

Michael Berman, Chairman 
Industry Expert, medical device investor/entrepreneur who serves on the boards of 11 emerging medical companies

Scientific Advisors

Prof. Gady Har-El, M.D.
Chairman, Otolaryngology-Head and Neck Surgery, Lenox Hill Hospital, New York

Prof. Eitan Yaniv, M.D.
Head of Nose and Sinus Institute, Rabin Medical Center, Israel; leading surgeon in the ENT field

Strategic & Business Development Advisor
Chas McKhann, MBA Stanford University School of Business
Chief Commercial Officer in Intersect ENT 2015-2016, leading corporate Strategy, Business Development, and M&A activities.
Former VP of Marketing, Boston Scientific
Former Director of Marketing, Cordis J&J


EU flag
This project has received funding from the European Union,
Horizon 2020 research and innovation programme under grant
agreement No 827197_STstent Grant Agreement